Home Page | Deseases | Crohn's and Colitis
Our Products
Crohn's and Colitis
 Indications by the Israeli Ministry of Health:
 
► Gastroenterological Field:
 
- Crohn’s Disease- For patients that aren’t responding to conventional treatment options well enough.
 
- Colitis- In special cases, it will be given to patients with ulcerative colitis that aren’t responding to conventional treatment options.
 
We provide professional counseling for treatment and strains to our patients, in a set meeting with one of our registered nurses in our clinic.
Research
 
Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study
 
Timna Naftaliemail, Lihi Bar-Lev Schleider, Iris Dotan, Ephraim Philip Lansky, Fabiana Sklerovsky Benjaminov, Fred Meir Konikoff
Published Online: May 06, 2013
 
http://www.cghjournal.org/article/S1542-3565(13)00604-6/abstract

All Patients Stated a Positive Effect on their Crohn's Disease Activity

The retrospective research study was conducted by interviewing patients suffering from  Crohn’s disease.The study has found very positive effects on the symptoms of the disease (number of bowel movements, quality of bowel activity, blood in stool samples, pain, etc.).

Head Researcher: Dr. Timna Naftali, Gastroenterology

Hospital: Meir Medical Center, Kfar Saba, Israel

Published in: IMAJ - The Israel Medical Association Journal, 2011

To download the full study click here


Crohn's patients treated with medical cannabis have a significantly reduced risk of complications from the disease

Chimezie Mbachi, USA 

Digestive Diseases and Sciences, 2019

https://link.springer.com/article/10.1007/s10620-019-05556-z


 

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
 
Mol Med. 2009 Nov;87(11):1111-21. Epub 2009 Aug 20
Borrelli F, Aviello G, Romano B, Orlando P, Capasso R, Maiello F, Guadagno F, Petrosino S, Capasso F, Di Marzo V, Izzo AA
Department of Experimental Pharmacology, University of Naples Federico II, via D Montesano 49, 80131 Naples, Italy
 

 
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage,inflammation and in vitro motility disturbances in rat colitis
 
Jamontt JM, Molleman A, Pertwee RG, Parsons ME
School of Life Sciences, University of Hertfordshire, Hatfield, Hertfordshire, UK. J.M.Jamontt@herts.ac.uk
 

 

Our Products
Our Research Summary
 

Tikun Olam is on the cutting edge of medical cannabis research, using its proprietary strains and products in ongoing clinical trials in Israel's regulated market, with exceptional results and treatment success.

Operating for over a decade, Tikun Olam continues to develop and initiate partnerships and collaborations with physicians and scientists, led by Lihi Bar-Lev Schleider, a PhD student at the Ben-Gurion University of the Negev. 

Tikun Olam's patients data analysis overseen by Professor Victor Novack, Head of Soroka Clinical Research Center. Professor Raphael Mechoulam from the Hebrew university, has been involved in many of the published studies, along with many other pioneering researchers. 

Below the status of the studies:

 
 

Cannabis in ASD patients

Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy

80.1% of children should Improvement after Treatment with Avidekel and Erez strains extracts.

Chief Researcher: Lihi Bar-Lev Schleider, Soroka University Medical Center Full article
 

Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities

75% Improvement in ASD Comorbidities Symptoms, 43.1% Stated a Significant Improvement

Avidekel and Erez strains extracts used in retrospective cohort study examined the effects on 53 children and adolescents diagnosed with ASD.

Dr. Orit Stoler, Assaf Harofeh Medical Center, Israel Full article

 

Treatment of Crohn’s Disease with Cannabis- An Observational Study:

All Patients Stated a Positive Effect on their Crohn's Disease Activity

The retrospective research study was conducted by interviewing patients suffering from  Crohn’s disease.The study has found very positive effects on the symptoms of the disease (number of bowel movements, quality of bowel activity, blood in stool samples, pain, etc.).

Head Researcher: Dr. Timna Naftali, Gastroenterology

Hospital: Meir Medical Center, Kfar Saba, Israel

Published in: IMAJ - The Israel Medical Association Journal, 2011

To download the full study click here